Armstrong, A. J., Gupta, S., Healy, P., Kemeny, G., Leith, L. B., Zalutsky, M., … George, D. J. (2018). Genomic and phenotypic evidence for prostate cancer osteomimicry in circulating tumor cells from men with metastatic castration resistant prostate cancer (mCRPC) treated with radium-223. In Journal of Clinical Oncology (Vol. 36, pp. 5029–5029). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2018.36.15_suppl.5029

Armstrong, Andrew J., Santosh Gupta, Patrick Healy, Gabor Kemeny, Lauren Beth Leith, Michael Zalutsky, Charles Spritzer, et al. “Genomic and phenotypic evidence for prostate cancer osteomimicry in circulating tumor cells from men with metastatic castration resistant prostate cancer (mCRPC) treated with radium-223.” In Journal of Clinical Oncology, 36:5029–5029. American Society of Clinical Oncology (ASCO), 2018. https://doi.org/10.1200/jco.2018.36.15_suppl.5029.

Armstrong AJ, Gupta S, Healy P, Kemeny G, Leith LB, Zalutsky M, et al. Genomic and phenotypic evidence for prostate cancer osteomimicry in circulating tumor cells from men with metastatic castration resistant prostate cancer (mCRPC) treated with radium-223. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 5029–5029.

Armstrong, Andrew J., et al. “Genomic and phenotypic evidence for prostate cancer osteomimicry in circulating tumor cells from men with metastatic castration resistant prostate cancer (mCRPC) treated with radium-223.” Journal of Clinical Oncology, vol. 36, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2018, pp. 5029–5029. Crossref, doi:10.1200/jco.2018.36.15_suppl.5029.

Armstrong AJ, Gupta S, Healy P, Kemeny G, Leith LB, Zalutsky M, Spritzer C, Davies C, Rothwell C, Ware K, Somarelli J, Wood K, Ribar T, Gerber D, Anand M, Halabi S, Gregory S, George DJ. Genomic and phenotypic evidence for prostate cancer osteomimicry in circulating tumor cells from men with metastatic castration resistant prostate cancer (mCRPC) treated with radium-223. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2018. p. 5029–5029.